1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CTB-50L17.10 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA ZNF664 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA ZNF724 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA CRIPT CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA WHSC1L1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA RNF219 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA ZCCHC7 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA PCNA CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA AP4M1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA LIN9 CTRPv2 pan-cancer AAC 0.14 2e-05
Download CSV